Authors
Askadinov M.N.1, Kadyraliev B.K.1, Kucherenko S.V.2, Musaev O.G.1, Arutyunyan V.B.1
1 The Federal Center for Cardiovascular Surgery named after S.G. Sukhanov, Ministry of Health of the Russian Federation
2 Perm State Medical University named after Academician E. A. Wagner, Ministry of Health of the Russian Federation
Abstract
With degenerative defects of the aortic valve, a treatment method since the 1960s. is the excision of altered valves with implantation of a prosthetic valve. Most often, mechanical and biological prostheses are used, but each of them has problems with the need for lifelong anticoagulant therapy, thromboembolic and hemorrhagic complications, as well as negative indicators of mechanical valves compared to biological valves. Biological prostheses undergo degeneration quite quickly, especially in young patients, which leads to the need for reoperation. Despite the continuous change and modification of artificial valves, it can be concluded that an ideal aortic valve prosthesis has not yet been created.
Attempts have been made to replace some of the valves with various artificial and biological materials, but this, as a rule, is not widespread. In 2007 Shigeyuki Ozaki proposed a procedure for prosthetics of all aortic valve folds from the autopericardium treated with 0.6% glutaraldehyde solution [4]. Despite promising results, this Ozaki operation has not yet become widespread among cardiac surgeons. We will present you a literary review of the latest publications of the Ozaki operation for aortic valve disease.
Keywords: prosthesis, autologous pericardium, Ozaki.
References
1. Komiya T. Aortik valve repair update. Gen. Thorac Cardiovasc Surg. 2015;63(6):309–19. Doi: 10.1007/s11748-015-0523-1.
2. Mazzitelli D, Stamm C, Rankin JS, et al. Leaflet reconstructive techniques for aortic valve repair. Ann. Thorac Surg. 2014;98(6):2053–2060. Doi: 10.1016/j.athoracsur.2014.06.052.
3. Liu X, Han L, Song Z, et al. Aortic valve replacement with autologous pericardium: Long-term follow-up of 15 patients and in vivo histopathological changes of autologous pericardium. Interact. Cardiovasc. Thorac Surg. 2013;16(2):123–28. Doi: 10.1093/icvts/ivs441.
4. Ozaki S, Kawase I, Yamashita H, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12(4):550–3. Doi: 10.1510/icvts.2010.253682.
5. Ozaki S, Kawase I, Yamashita H, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J. Thorac. Cardiovasc. Surg. 2014;147(1):301–306. Doi: 10.1016/j.jtcvs.2012.11.012.
6. Ozaki S, Kawase I, Yamashita H, et. al. Aortic valve reconstruction using autologous pericardium for ages over 80 years. Asian Cardiovasc. Thorac. Ann. 2014;22(8):903–908. Doi: 10.1177/0218492314520748.
7. Ozaki S, Kawase I, Yamashita H, et al. Aortic valve reconstruction using autologous pericardium for aortic stenosis. Circ J. 2015;79(7):1504–1510. Doi: 10.1253/circj.CJ-14-1092.
8. Ozaki S, Kawase I, Yamashita H, et al. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J. Thorac. Cardiovasc. Surg. 2018;155(6):2379–2387. Doi: 10.1016/j.jtcvs.2018.01.087.
9. Ozaki S. Ozaki Procedure: 1,100 patients with up to 12 years of follow-up. Turkish Journal of Thoracic and Cardiovascular Surgery. 2019;27(4):454. Doi: 10.5606/tgkdc.dergisi.2019.01904.
10. Akiyama S, Iida Y, Shimura K, et al. Midterm outcome of aortic valve neocuspidization for aortic valve stenosis with small annulus. Gen Thorac Cardiovasc Surg. 2020;68(8):762–767. Doi: 10.1007/s11748-020-01299-1.
11. Reuthebuch O, Koechlin L, Schurr U, et al. Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique. Swiss Med. Wkly. 2018;148:w14591. Doi: 10.4414/smw.2018.14591.
12. Iida Y, Fujii S, Akiyama S, Sawa S. Early and mid-term results of isolated aortic valve neocuspidization in patients with aortic stenosis. Gen. Thorac. Cardiovasc. Surg. 2018;66(11):648–52. Doi: 10.1007/s11748-018-0976-0.
13. Nguyen DH, Vo AT, Le KM, et al. Minimally Invasive Ozaki procedure in aortic valve disease: the preliminary results. Innovations (Phila). 2018;13(5):332–7. Doi: 10.1097/ IMI.0000000000000556.
14. Mourad F, Shehada SE, Lubarski J, et al. Aortic valve construction using pericardial tissue: short-term singlecentre outcomes. Interact. Cardiovasc. Thorac. Surg. 2019;28(2):183–90. Doi: 10.1093/icvts/ivy230.
15. Krane M, Boehm J, Prinzing A, Lange R. Excellent hemodynamic results in patients undergoing the Ozaki procedure for aortic valve reconstruction within the first year. Thorac. Cardiovasc. Surg. 2019;67(1):1–100. Doi: 10.1055/s-0039-1678893.
16. Kwak YJ, Ahn H, Choi JW, Kim KH. Long-term results of the leaflet extension technique for rheumatic aortic regurgitation: a 20-year follow-up. Korean J. Thorac. Cardiovasc. Surg. 2019;52(1):9–15. Doi: 10.5090/ kjtcs.2019.52.1.9.
17. Ahn H, Kim KH., Kim YJ. Midterm results of leaflet extension technique in aortic regurgitation. Eur. J. Cardiothorac. Surg. 2002;21(3):465–9. Doi: 10.1016/s1010-7940(01)01150-2.
18. Jeong DS, Kim KH, Ahn H. Long-term results of the leaflet extension technique in aortic regurgitation: thirteen years of experience in a single center. Ann. Thorac. Surg. 2009;88(1):83–9. Doi: 10.1016/j. athoracsur.2009.04.011.
